Join CurePSP for Ask the Scientist: Dr. Günter U. Höglinger
Dr. Höglinger will be discussing mPSPRS and PSP-CDS. Why do we need two new scales?
The Progressive Supranuclear Palsy (PSP) Rating Scale is a prospectively validated physician-rated measure of disease severity for progressive supranuclear palsy. We hypothesized that, according to experts’ opinion, individual scores of items would differ in relevance for patients’ quality of life, functionality in daily living, and mortality. Thus, changes in the score may not equate to clinically meaningful changes in the patient’s status.
Since 1990, CurePSP has provided funding to more than 200 researchers for a cumulative investment of $20 million. CurePSP’s objective is to provide scientists with seed funding opportunities so they can develop the necessary proof of concept to validate innovative ideas and qualify for larger funding sources. CurePSP funds researchers focusing on the underlying molecular and cellular mechanisms of PSP, CBD, and other neurodegenerative disorders. CurePSP aims to also enable researchers to focus on translational clinical studies involving patients.
This webinar is technical in nature and is intended for research and healthcare professional audiences.
The 40-minute live webinar will be followed by fifteen minutes of Q&A. Please send any questions you would like to ask Dr. Höglinger to email@example.com. You can also submit them as part of the registration process or during the presentation as well.
Professor Höglinger conducts research in the field of neurodegenerative Parkinson syndromes with the goal of understanding the molecular mechanisms leading to the development and progression of neuronal dysfunction and death and of using these findings for diagnostic and therapeutic purposes. His particular focus is the interface between preclinical and clinical research.
Günter Höglinger studied medicine and physics at the universities of Regensburg and Würzburg. He earned his PhD in medicine, summa cum laude, in 2000. Supported by a grant from the German Research Foundation, DFG, he worked as a postdoctoral researcher at the Hôpital de la Salpêtrière in Paris. Since 2004 he has directed the experimental neurology research group at Philipps University Marburg. In Marburg, he also acquired his German medical board certification in neurology and went on to work as the Vice Director of the Department of Neurology. Since 2011 he has worked as a senior consultant at TUM’s Department of Neurology and holds the Chair of the Department of Translational Neurodegeneration at the German Center for Neurodegenerative Diseases, DZNE. From 2019 on, he is the President of the German Parkinson Association.
The registration link will be emailed out one hour before the beginning of the event and again ten minutes before the event. This webinar will be recorded.